News about Drug Discovery & Development

Formosa Pharma Signs Licensing Deal with DAVI for Clobetasol Propionate Ophthalmic Suspension

The DÁVI licensing agreement includes upfront, commercialization milestones, and sales milestones, with additional considerations throughout the term of the agreement.

Drug Discovery & Development | 04/11/2024 | By Aishwarya |  675

AbbVie and EvolveImmune to Develop Next-Gen Cancer Biotherapeutics

EvolveImmune's proprietary EVOLVE platform is designed to deliver potent, selective and integrated T-cell co-stimulation to amplify and sustain the tumor killing capacity of the T-cells.

Drug Discovery & Development | 01/11/2024 | By Aishwarya |  382

GC Biopharma Partners with Novelty Nobility to Jointly Research for Geographic Atrophy Therapies

Under the terms of the agreement, GC Biopharma and Novelty Nobility established a partnership to jointly research and develop antibody-based protein therapeutics for GA throughout all stages of the drug development lifecycle.

Drug Discovery & Development | 28/10/2024 | By Aishwarya |  268

Viatris Signs Licensing Deal with Lexicon Pharmaceuticals for Sotagliflozin

This licensing agreement leverages Viatris' expertise in cardiovascular diseases and its Global Healthcare Gateway, which offers partners ready access to more markets and patients worldwide through the company's unique global infrastructure and expertise.

Drug Discovery & Development | 18/10/2024 | By Aishwarya |  658

Kvantify Launches New Computational Method for Drug Discovery

The method stands out significantly from other solutions on the market and is a strong addition to Kvantify's computational drug discovery platform, Koffee.

Drug Discovery & Development | 14/10/2024 | By Aishwarya |  369

Lipocine Signs Supply and Distribution Deal with Pharmalink to Commercialize TLANDO

Under the terms of the agreement, Lipocine received an upfront payment from Pharmalink and, upon Marketing Authorizations (MA) in individual GCC countries, Lipocine will provide TLANDO drug products to Pharmalink at an agreed transfer price.

Drug Discovery & Development | 11/10/2024 | By Aishwarya |  267

Alkem Laboratories Signs Licensing Deal with Sonnet BioTherapeutics

Under the licensing agreement, Alkem will carry out the clinical development of 'SON-080' in India with support from Sonnet and enable global and India regulatory filings.

Drug Discovery & Development | 10/10/2024 | By Aishwarya |  477

Sun Pharma Signs Global Exclusive Deal with Philogen for Commercializing FIBROMUN

Under the terms of the agreement, Sun Pharma will have the exclusive worldwide rights to commercialise Fibromun.

Drug Discovery & Development | 01/10/2024 | By Aishwarya |  476

Alembic Gets FDA Approval for Paliperidone Extended-Release Tablets

Paliperidone extended-release tablets are an atypical antipsychotic agent indicated for Treatment of schizophrenia and it is also indicated for treatment of schizoaffective disorder as monotherapy and as an adjunct to mood stabilizers and/or antidepressants.

Drug Discovery & Development | 30/09/2024 | By Aishwarya |  479

AstraZeneca India Secures CDSCO Approval for Durvalumab

AstraZeneca Pharma India has been granted permission to import for sale and distribution of Durvalumab 120 mg/2.4 mL and 500 mg/10 mL solution for infusion from the Central Drugs Standard Control Organisation (CDSCO).

Drug Discovery & Development | 27/09/2024 | By Aishwarya |  530